Hence, the study we conducted strives to identify novel MDM2 inhibitors for BC to improve therapy efficacy, combat resistance, and reduce side effects, ultimately offering patients more individualized and efficient therapeutic options. The gene discussed is MDM2; the disease is breast cancer.